SNB-101 for Treatment of Extensive Stage Small Cell Lung Cancer

Clinical trial NCT07391813 · RECRUITING

Trial details

NCT number: NCT07391813
Sponsor: SN BioScience
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Patient is Not Suitable for Complete Surgical Resection With a Cytologically or Histologically Confirmed Small Cell Lung Cancer(SCLC)

Start date: 2026-03-01
Primary completion: 2028-12-01
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.